Henry Yau – Managing Director, HKU Clinical Trials Centre
Last Autumn, the Hong Kong government announced a plan to create a one-stop-shop clinical trial institute across the Greater Bay Area (GBACTI) as part of its plan to promote biomedical…
At Sanwa BioTech, we believe that impending changes are coming to the way to conventional clinical diagnostic & academic R&D for bio-discoveries. We aim to become a driving force for these changes to revolutionize healthcare solutions into the future. Sanwa BioTech delivers accurate and actionable information through our disposable Lab-On-Chip (LOC) rapid diagnostic platform, resulting in transformative diagnostic tests for faster clinical decisions and better economic outcomes.
At Sanwa Biotech, we provide diagnostic solutions based on our microfluidic disposable Lab-On-Chip (LOC) platform, including an integrative point of care device, reagents, software analytics & data management service, which brings convenience and value in diseases monitoring and supports clinical decisions, improves patients health and contributes to innovative solutions that combat challenges on global health care.
Contact
Unit 627, 6/F, BioTech Centre Two,
No.11 Science Park West Avenue,
Hong Kong Science Park,
Shatin, Hong Kong SAR,
CHINA
Unit 2, 5/F.,
Wah Lai Industrial Centre,
10-14 Kwei Tei Street,
Fo Tan, Hong Kong SAR,
CHINA
Tel: +852 2698 9903
Website: http://sanwabiotech.com/en/index.html
Email: inquiry@sanwabiotech.com
Last Autumn, the Hong Kong government announced a plan to create a one-stop-shop clinical trial institute across the Greater Bay Area (GBACTI) as part of its plan to promote biomedical…
VMS Group was founded in 2006 and since then has built close relationships with a handful of large anchor investors, including some of the largest families in Hong Kong. Apart…
Haematological oncologist Dr Raymond Liang, gives his take on the adoption and challenges of CAR-T therapy in Hong Kong, the necessity of collaboration with mainland China for patient referrals and…
Hong Kong Exchanges and Clearing Limited (HKEX) chief executive Nicolas Aguzin has stepped down after a term fraught with upheaval. Having survived COVID-19 isolation, under Aguzin HKEX was confronted with…
Although well-established as Asia’s leading financial services and trading hub, Hong Kong has never truly been globally competitive in the innovation and technology space, despite piecemeal initiatives to bolster its…
While much of PharmaBoardroom’s recent report on Hong Kong and the Greater Bay Area looks at how Hong Kong is attempting to position itself as a development and financing hub…
Hong Kong provides some of the best and most efficient healthcare in Asia, with Hong Kongers living to over 85 on average (compared to 83 in Singapore and 78 in…
A decade on from its launch, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative has made some significant wins but remains some way from fulfilling the vision of a fully…
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to receive the funding it needs to progress. It…
Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons, Professor Dennis Lo, is aiming to change the…
Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within the global clinical research…
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on its established areas of finance and…
See our Cookie Privacy Policy Here
